Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced the completion of target enrollment of 198 participants for its pivotal Phase 3 registration trial (“REVEAL 1”) of VGX-3100, a novel …
Category: Health
Acasti Pharma Inc. (NASDAQ:ACST) loss for fiscal 2019 expanded from $21.5 million in the prior year to $51.6 million due to higher R&D costs for the TRILOGY Phase …
Akorn, Inc. (NASDAQ:AKRX) said that it received a warning letter from the Food and Drug Administration related to the inspection of its Somerset, New Jersey manufacturing …
AbbVie Inc. (NYSE:ABBV) and Allergan plc announced that the companies have entered into a definitive transaction agreement under which AbbVie will acquire Allergan in a cash and stock transaction for …
Bristol-Myers Squibb Company (NYSE:BMY) provided update on approval process with Celgene Corporation
Bristol-Myers Squibb Company (NYSE:BMY) provided an update on the approval process and timeline for the Company’s pending merger with Celgene Corporation. The Company remains actively engaged in …
Lehigh Valley Health Network and CVS Health Corporation (NYSE:CVS) announced a five-year partnership Monday to share patient data to design programs aimed at lowering costs …
Affimed N.V. (NASDAQ:AFMD) declined after announcing clinical data update on lead product candidate AFM13 in CD30+ lymphoma at the ICML 2019. Affimed N.V. (NASDAQ:AFMD), a Healthcare sector …
Minerva Neurosciences, Inc. (NASDAQ:NERV) seltorexant helped patients fall asleep more quickly and stay asleep for longer, beating placebo and Sanofi’s insomnia med Ambien in a phase 2b …
Given the significant increase in the number of teens using e-cigarettes, CVS Health Corporation (NYSE:CVS) announced that it and its charitable foundations will award a total …
Merck & Co., Inc. (NYSE:MRK) Executive Ken Frazier said a rule to base the price the U.S. government pays for some prescription drugs in it Medicare …
Pfizer Inc. (NYSE:PFE) has received approval from the European Commission for its TALZENNA a breast cancer drug. This approval follows the medicine’s approval by the U.S. …